Healthcare provider profile · identity verified

Kristen Ingram, MD

Family Practice · SALEM, IN · NPI 1689626038

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	495	125
Lisinopril	Lisinopril	367	90
Levothyroxine Sodium	Levothyroxine Sodium	346	80
Albuterol Sulfate Hfa	Albuterol Sulfate	301	55
Rosuvastatin Calcium	Rosuvastatin Calcium	292	74
Amlodipine Besylate	Amlodipine Besylate	277	76
Omeprazole	Omeprazole	264	73
Gabapentin	Gabapentin	240	43
Escitalopram Oxalate	Escitalopram Oxalate	229	49
Meloxicam	Meloxicam	223	40
Pantoprazole Sodium	Pantoprazole Sodium	215	50
Metoprolol Succinate	Metoprolol Succinate	206	48
Metoprolol Tartrate	Metoprolol Tartrate	205	46
Metformin Hcl	Metformin Hcl	199	53
Mounjaro	Tirzepatide	170	26
Trazodone Hcl	Trazodone Hcl	168	36
Tamsulosin Hcl	Tamsulosin Hcl	139	32
Furosemide	Furosemide	137	33
Sertraline Hcl	Sertraline Hcl	132	30
Hydrochlorothiazide	Hydrochlorothiazide	128	29
Fluoxetine Hcl	Fluoxetine Hcl	127	18
Montelukast Sodium	Montelukast Sodium	122	25
Potassium Chloride	Potassium Chloride	119	24
Buspirone Hcl	Buspirone Hcl	114	26
Tizanidine Hcl	Tizanidine Hcl	112	29
Clopidogrel	Clopidogrel Bisulfate	111	29
Fluticasone Propionate	Fluticasone Propionate	106	32
Jardiance	Empagliflozin	103	19
Ozempic	Semaglutide	101	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	22
Zolpidem Tartrate	Zolpidem Tartrate	92	14
Simvastatin	Simvastatin	87	18
Allopurinol	Allopurinol	85	18
Alendronate Sodium	Alendronate Sodium	81	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	77	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	15
Atenolol	Atenolol	73	19
Azithromycin	Azithromycin	68	61
Donepezil Hcl	Donepezil Hcl	67	15
Pregabalin	Pregabalin	67	12
Tramadol Hcl	Tramadol Hcl	67	12
Baclofen	Baclofen	62	suppressed
Losartan Potassium	Losartan Potassium	62	19
Celecoxib	Celecoxib	61	13
Ropinirole Hcl	Ropinirole Hcl	61	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	12
Duloxetine Hcl	Duloxetine Hcl	60	12
Eliquis	Apixaban	57	11
Memantine Hcl	Memantine Hcl	56	11
Spironolactone	Spironolactone	55	suppressed
Carvedilol	Carvedilol	53	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	11
Aripiprazole	Aripiprazole	46	11
Breo Ellipta	Fluticasone/Vilanterol	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Trulicity	Dulaglutide	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	45	12
Pravastatin Sodium	Pravastatin Sodium	45	suppressed
Symbicort	Budesonide/Formoterol Fumarate	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Glimepiride	Glimepiride	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	suppressed
Bupropion Xl	Bupropion Hcl	38	suppressed
Famotidine	Famotidine	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Bumetanide	Bumetanide	36	suppressed
Hydrocortisone	Hydrocortisone	35	13
Januvia	Sitagliptin Phosphate	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Fenofibrate	Fenofibrate	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Metformin Hcl Er	Metformin Hcl	30	suppressed
Ondansetron Odt	Ondansetron	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Rizatriptan	Rizatriptan Benzoate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	suppressed
Methylprednisolone	Methylprednisolone	28	25
Spiriva Respimat	Tiotropium Bromide	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Estradiol	Estradiol	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	25	suppressed
Glipizide	Glipizide	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Temazepam	Temazepam	25	suppressed
Theophylline Er	Theophylline Anhydrous	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Fluconazole	Fluconazole	24	14
Meclizine Hcl	Meclizine Hcl	24	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	16
Cefdinir	Cefdinir	18	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Novolin N	Insulin Nph Human Isophane	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Risperidone	Risperidone	15	suppressed
Diazepam	Diazepam	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Prednisone	Prednisone	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Tudorza Pressair	Aclidinium Bromide	13	suppressed
Valsartan	Valsartan	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Digoxin	Digoxin	12	suppressed
Invokana	Canagliflozin	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ramipril	Ramipril	11	suppressed
Topiramate	Topiramate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error